Prevention of amyloid-β fibril formation using antibodies against the C-terminal region of amyloid-β1-40 and amyloid-β 1-42

Journal of Alzheimer's Disease

Volumn 34, Issue 1, 2013, Pages 133-137

  Montañés, María ^a   Casabona, Diego ^a   Sarasa, Leticia ^b   Pesini, Pedro ^a,b   Sarasa, Manuel ^a,b  

^a CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

^b Araclon Biotech   (Spain)

Author keywords

Aggregation; Alzheimer's disease; Thioflavin T

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; ANTIBODY; HEXAFLUORO 2 PROPANOL; THIOFLAVINE;

ALZHEIMER DISEASE; ARTICLE; CARBOXY TERMINAL SEQUENCE; FLUORESCENCE; IN VITRO STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PURIFICATION;

EID: 84874343214     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-120850     Document Type: Article

References (26)

1. Zagorski MG, Yang J, Shao H, Ma K, Zeng H, Hong A (1999) Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity. Methods Enzymol 309, 189-204. (Pubitemid 29446450)
2. LeVine H III (1993) Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci 2, 404-410.
3. LeVine H III (1997) Stopped-flow kinetics reveal multiple phases of thioflavin T binding to Alzheimer beta (1-40) amyloid fibrils. Arch Biochem Biophys 342, 306-316.
4. Manzoni C, Colombo L, Messa M, Cagnotto A, Cantu L, Del FE, Salmona M (2009) Overcoming synthetic Abeta peptide aging: A new approach to an age-old problem. Amyloid 16, 71-80.
5. Kirschner DA, Inouye H, Duffy LK, Sinclair A, Lind M, Selkoe DJ (1987) Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc Natl Acad Sci U S A 84, 6953-6957.
6. Gorevic PD, Castano EM, Sarma R, Frangione B (1987) Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic xray diffraction pattern. Biochem Biophys Res Commun 147, 854-862. (Pubitemid 18007025)
7. Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yates J, Cotman C, Glabe C (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem 267, 546-554.
8. LeVine H, III (1999) Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol 309, 274-284.
9. Naiki H, Nakakuki K (1996) First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro. Lab Invest 74, 374-383. (Pubitemid 26072080)
10. Ono K, Condron MM, Ho L, Wang J, Zhao W, Pasinetti GM, Teplow DB (2008) Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity. J Biol Chem 283, 32176-32187.
11. Bitan G, Lomakin A, Teplow DB (2001) Amyloid betaprotein oligomerization: Prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J Biol Chem 276, 35176-35184.
12. Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, TeplowDB (2003) Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A 100, 330-335. (Pubitemid 36078074)
13. LeVine H III (2004) Alzheimer's beta-peptide oligomer formation at physiologic concentrations. Anal Biochem 335, 81-90.
14. Stine WB Jr, Dahlgren KN, Krafft GA, LaDu MJ (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem 278, 11612-11622. (Pubitemid 36792723)
15. Wood SJ, Maleeff B, Hart T, Wetzel R (1996) Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta. J Mol Biol 256, 870-877. (Pubitemid 26108825)
16. Zagorski MG, Barrow CJ (1992) NMR studies of amyloid beta-peptides: Proton assignments, secondary structure, and mechanism of an alpha-helix-beta-sheet conversion for a homologous, 28-residue, N-terminal fragment. Biochemistry 31, 5621-5631.
17. Solomon B, Koppel R, Hanan E, Katzav T (1996) Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide. Proc Natl Acad Sci U S A 93, 452-455. (Pubitemid 26038175)
18. Solomon B, Koppel R, Frankel D, Hanan-Aharon E (1997) Disaggregation of Alzheimer beta-amyloid by site-directed mAb. Proc Natl Acad Sci U S A 94, 4109-4112. (Pubitemid 27180507)
19. Harper JD, Lansbury PT Jr (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66, 385-407. (Pubitemid 27274662)
20. Lemere CA, Masliah E (2010) Can Alzheimer disease be prevented by amyloid-beta immunotherapy? Nat Rev Neurol 6, 108-119.
21. Hung LW, Ciccotosto GD, Giannakis E, Tew DJ, Perez K, Masters CL, Cappai R, Wade JD, Barnham KJ (2008) Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity. J Neurosci 28, 11950-11958.
22. Pauwels K, Williams TL, Morris KL, Jonckheere W, Vandersteen A, Kelly G, Schymkowitz J, Rousseau F, Pastore A, Serpell LC, Broersen K (2011) The structural basis for increased toxicity of pathological Abeta42 : Abeta40 ratios in Alzheimer's disease. J Biol Chem 287, 5650-5660.
23. Wiltfang J, Esselmann H, Bibl M, Smirnov A, Otto M, Paul S, Schmidt B, Klafki HW, Maler M, Dyrks T, Bienert M, Beyermann M, Ruther E, Kornhuber J (2002) Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation. J Neurochem 81, 481-496. (Pubitemid 34809327)
24. Schilling S, Lauber T, Schaupp M, Manhart S, Scheel E, Bohm G, Demuth HU (2006) On the seeding and oligomerization of pGlu-amyloid peptides (in vitro). Biochemistry 45, 12393-12399. (Pubitemid 44583682)
25. Portelius E, Westman-Brinkmalm A, Zetterberg H, Blennow K (2006) Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry. J Proteome Res 5, 1010-1016.
26. Lansbury PT Jr (1997) Structural neurology: Are seeds at the root of neuronal degeneration? Neuron 19, 1151-1154. (Pubitemid 28030534)